Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer

Kensler, 2016, Transforming cancer prevention through precision medicine and immune-oncology, Cancer Prev. Res. (Phila.), 9, 2, 10.1158/1940-6207.CAPR-15-0406 Bauman, 2016, Prevention of carcinogen-induced oral cancer by sulforaphane, Cancer Prev. Res. (Phila.), 9, 547, 10.1158/1940-6207.CAPR-15-0290 Meyskens, 2015, Cancer prevention: obstacles, challenges and the road ahead, J. Natl. Cancer Inst., 108, djv309 Dunn, 2016, Cancer prevention: lessons learned and future directions, Trends Cancer, 2, 713, 10.1016/j.trecan.2016.11.003 Finn, 2018, The dawn of vaccines for cancer prevention, Nat. Rev. Immunol., 18, 183, 10.1038/nri.2017.140 American Cancer Society, 2015 Maguire, 2016, 1988 2018 Choi, 2016, From benchtop to bedside: a review of oncolytic virotherapy, Biomedicines, 4, E18, 10.3390/biomedicines4030018 Woo, 2006, Advances in oncolytic viral therapy, Curr. Opin. Investig. Drugs, 7, 549 Adusumilli, 2006, Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging, Surg. Endosc., 20, 628, 10.1007/s00464-005-0259-6 Adusumilli, 2006, Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery, FASEB J., 20, 726, 10.1096/fj.05-5316fje Eisenberg, 2006, Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus, Ann. Surg., 243, 824, 10.1097/01.sla.0000219738.56896.c0 Stanziale, 2004, Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer, Hum. Gene Ther., 15, 609, 10.1089/104303404323142051 Stiles, 2006, Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer, Cancer Gene Ther., 13, 53, 10.1038/sj.cgt.7700860 Adusumilli, 2011, Fluorescence-assisted cytological testing (FACT): ex vivo viral method for enhancing detection of rare cancer cells in body fluids, Mol. Med., 17, 628, 10.2119/molmed.2011.00078 Coelen, 2017, In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus, Cancer Gene Ther., 24, 227, 10.1038/cgt.2017.11 Gholami, 2014, Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer, Cancer Gene Ther., 21, 283, 10.1038/cgt.2014.28 Gil, 2008, Utility of a herpes oncolytic virus for the detection of neural invasion by cancer, Neoplasia, 10, 347, 10.1593/neo.07981 Stanziale, 2004, Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity, Clin. Cancer Res., 10, 3225, 10.1158/1078-0432.CCR-1083-3 Vairaktaris, 2008, The hamster model of sequential oral oncogenesis, Oral Oncol., 44, 315, 10.1016/j.oraloncology.2007.08.015 Campadelli-Fiume, 2012, Viral and cellular contributions to herpes simplex virus entry into the cell, Curr. Opin. Virol., 2, 28, 10.1016/j.coviro.2011.12.001 Hadigal, 2013, Exploiting herpes simplex virus entry for novel therapeutics, Viruses, 5, 1447, 10.3390/v5061447 Shukla, 2006, Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain, Appl. Immunohistochem. Mol. Morphol., 14, 341, 10.1097/00129039-200609000-00014 Yoon, 2002, Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry, J. Virol., 76, 7203, 10.1128/JVI.76.14.7203-7208.2002 Yu, 2007, Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity, Mol. Ther., 15, 103, 10.1038/sj.mt.6300009 Adusumilli, 2005, Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer, Ann. Thorac. Surg., 80, 409, 10.1016/j.athoracsur.2005.01.048 Mullerad, 2005, Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma, J. Urol., 174, 741